{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:03:13Z","timestamp":1793473393430,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ejpn-journal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejpn.2024.04.009","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T11:27:27Z","timestamp":1713785247000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Efficacy and safety of N-acetyl-L-leucine in patients with ataxia telangiectasia: A randomized, double-blind, placebo-controlled, crossover clinical trial"],"prefix":"10.1016","volume":"50","author":[{"given":"Mehran","family":"Beyraghi-Tousi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhosein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Houra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooria","family":"Sarvghadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tannaz","family":"Jamialahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima","family":"Tavallaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Gumpricht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Saberi-Karimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2024.04.009_bib1","first-page":"15","article-title":"A\u00a0familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection: a preliminary report on 7 children, an autopsy, and a case history","volume":"9","author":"Boder","year":"1957","journal-title":"Univ Southern Calif Med Bull."},{"issue":"7","key":"10.1016\/j.ejpn.2024.04.009_bib2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1056\/NEJMra1006610","article-title":"The autosomal recessive cerebellar ataxias","volume":"366","author":"Anheim","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"8\u20139","key":"10.1016\/j.ejpn.2024.04.009_bib3","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.dnarep.2004.04.010","article-title":"Ataxia\u2013telangiectasia, an evolving phenotype","volume":"3","author":"Chun","year":"2004","journal-title":"DNA Repair"},{"key":"10.1016\/j.ejpn.2024.04.009_bib4","first-page":"159","article-title":"Ataxia-telangiectasia: future prospects","volume":"7","author":"Chaudhary","year":"2014","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.ejpn.2024.04.009_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/B978-0-444-62702-5.00014-7","article-title":"Ataxia telangiectasia","volume":"132","author":"Nissenkorn","year":"2015","journal-title":"Handb. Clin. Neurol."},{"issue":"6","key":"10.1016\/j.ejpn.2024.04.009_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejpn.2007.04.001","article-title":"Alpha fetoprotein is increasing with age in ataxia\u2013telangiectasia","volume":"11","author":"Stray-Pedersen","year":"2007","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2024.04.009_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1203\/00006450-198101000-00012","article-title":"Serum alpha fetoprotein (AFP) levels in normal infants","volume":"15","author":"Wu","year":"1981","journal-title":"Pediatr. Res."},{"issue":"7","key":"10.1016\/j.ejpn.2024.04.009_bib8","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/dmcn.13424","article-title":"Ataxia-telangiectasia: recommendations for multidisciplinary treatment","volume":"59","author":"van Os","year":"2017","journal-title":"Dev. Med. Child Neurol."},{"issue":"10","key":"10.1016\/j.ejpn.2024.04.009_bib9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrm2514","article-title":"Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer","volume":"9","author":"Lavin","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"20","key":"10.1016\/j.ejpn.2024.04.009_bib10","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1007\/s00018-014-1666-4","article-title":"Functional interplay between ATM\/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress","volume":"71","author":"Yan","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.ejpn.2024.04.009_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ajhg.2008.07.003","article-title":"ATM gene mutations result in both recessive and dominant expression phenotypes of genes and microRNAs","volume":"83","author":"Smirnov","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ejpn.2024.04.009_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12017-013-8231-4","article-title":"Variant ataxia telangiectasia: clinical and molecular findings and evaluation of radiosensitive phenotypes in a patient and relatives","volume":"15","author":"Claes","year":"2013","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.ejpn.2024.04.009_bib13","series-title":"Ataxia-Telangiectasia in Children: Guidance on Diagnosis and Clinical Care","year":"2014"},{"issue":"1","key":"10.1016\/j.ejpn.2024.04.009_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-016-0786-x","article-title":"Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial","volume":"17","author":"Feil","year":"2017","journal-title":"BMC Neurol."},{"issue":"12","key":"10.1016\/j.ejpn.2024.04.009_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.35841","article-title":"Safety and efficacy of acetyl-DL-leucine in certain types of cerebellar ataxia: the ALCAT randomized clinical crossover trial","volume":"4","author":"Feil","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ejpn.2024.04.009_bib16","article-title":"Effects of acetyl-DL-leucine on ataxia and downbeat-nystagmus in six patients with ataxia telangiectasia","volume":"7","author":"Brueggemann","year":"2021","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ejpn.2024.04.009_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000148206","article-title":"Effects of acetyl-DLleucine in vestibular patients: a clinical study following neurotomy and labyrinthectomy","volume":"14","author":"Ferber-Viart","year":"2009","journal-title":"Audiol neuro-otol"},{"issue":"4","key":"10.1016\/j.ejpn.2024.04.009_bib18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.0953-816x.2000.01447.x","article-title":"In\u00a0vitro effects of acetyl-dl-leucine (tanganil\u00ae) on central vestibular neurons and vestibulo-ocular networks of the Guinea-pig","volume":"13","author":"Vibert","year":"2001","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.ejpn.2024.04.009_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229585","article-title":"Unexpected differences in the pharmacokinetics of N-acetyl-DL-leucine enantiomers after oral dosing and their clinical relevance","volume":"15","author":"Churchill","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejpn.2024.04.009_bib20","first-page":"1651","article-title":"Efficacy and safety of N-acetyl-l-leucine in Niemann-Pick disease type C","volume":"269","author":"Bremova-Ertl","year":"2022","journal-title":"J.\u00a0Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2024.04.009_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-016-0786-x","article-title":"Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial","volume":"17","author":"Feil","year":"2017","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2024.04.009_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-020-05009-3","article-title":"A\u00a0master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 Gangliosidoses, and Ataxia Telangiectasia","volume":"22","author":"Fields","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.ejpn.2024.04.009_bib23","unstructured":"Mohamadian H, Akbari H, Gilasi H, Gharlipour Z, Moazami A, Aghajani M. Validation of pediatric quality of life questionnaire (PedsQL) in Kashan city, (in Persian). J Ilam Univ Med Sci.;22(3):10-18."},{"issue":"6","key":"10.1016\/j.ejpn.2024.04.009_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1367\/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2","article-title":"The PedsQL\u2122\u2217 4.0 as a pediatric population health measure: feasibility, reliability, and validity","volume":"3","author":"Varni","year":"2003","journal-title":"Ambul. Pediatr."},{"key":"10.1016\/j.ejpn.2024.04.009_bib25","article-title":"Food composition table of Iran","volume":"vol. 65","author":"Azar","year":"1980"},{"issue":"1","key":"10.1016\/j.ejpn.2024.04.009_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-018-0880-9","article-title":"Annual severity increment score as a tool for stratifying patients with Niemann-Pick disease type C and for recruitment to clinical trials","volume":"13","author":"Cortina-Borja","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2024.04.009_bib27","doi-asserted-by":"crossref","first-page":"fcaa148","DOI":"10.1093\/braincomms\/fcaa148","article-title":"Acetyl-leucine slows disease progression in lysosomal storage disorders","volume":"3","author":"Kaya","year":"2021","journal-title":"Brain communications"},{"issue":"6","key":"10.1016\/j.ejpn.2024.04.009_bib28","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s12311-022-01504-2","article-title":"The effects of N-Acetyl-L-Leucine on the improvement of symptoms in a patient with multiple sulfatase deficiency","volume":"22","author":"Saberi-Karimian","year":"2023","journal-title":"Cerebellum"},{"issue":"3","key":"10.1016\/j.ejpn.2024.04.009_bib29","first-page":"183","article-title":"Alleviating children's postoperative pain","volume":"13","author":"O'brien","year":"1988","journal-title":"MCN Am. J. Matern.\/Child Nurs."},{"issue":"6","key":"10.1016\/j.ejpn.2024.04.009_bib30","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejpn.2024.04.009_bib31","first-page":"1","article-title":"The effect of N-Acetyl-DL-Leucine on neurological symptoms in a patient with ataxia-telangiectasia: a case study","volume":"7","author":"Saberi-Karimian","year":"2022","journal-title":"Cerebellum"},{"key":"10.1016\/j.ejpn.2024.04.009_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110729","article-title":"N-acetyl-L-leucine protects MPTP-treated Parkinson's disease mouse models by suppressing Desulfobacterota via the gut-brain axis","volume":"202","author":"Xu","year":"2023","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.ejpn.2024.04.009_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/08830738211028394","article-title":"Effects of acetyl-DL-leucine on ataxia and downbeat-nystagmus in six patients with ataxia telangiectasia","volume":"37","author":"Brueggemann","year":"2022","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ejpn.2024.04.009_bib34","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejphar.2015.11.041","article-title":"Comparative analysis of pharmacological treatments with N-acetyl-DL-leucine (Tanganil) and its two isomers (N-acetyl-L-leucine and N-acetyl-D-leucine) on vestibular compensation: behavioral investigation in the cat","volume":"769","author":"Tighilet","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejpn.2024.04.009_bib35","article-title":"N-acetyl-L-leucine treatment attenuates neuronal cell death and suppresses neuroinflammation after traumatic brain injury in mice","author":"Sarkar","year":"2019","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.ejpn.2024.04.009_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-88693-8","article-title":"N-Acetyl-l-leucine improves functional recovery and attenuates cortical cell death and neuroinflammation after traumatic brain injury in mice","volume":"11","author":"Hegdekar","year":"2021","journal-title":"Sci. Rep."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379824000552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379824000552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T20:33:05Z","timestamp":1726345985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379824000552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":36,"alternative-id":["S1090379824000552"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2024.04.009","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of N-acetyl-L-leucine in patients with ataxia telangiectasia: A randomized, double-blind, placebo-controlled, crossover clinical trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2024.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}